Science
Mechanism of Action
Hydroxypinacolone Retinoate (HPR) functions as an ester of all-trans retinoic acid, uniquely binding directly to retinoic acid receptors (RARs) within the skin. This direct activation bypasses the multi-step conversion process seen with other retinoids like retinol and retinaldehyde. Engaging RARs initiates signaling pathways that promote cellular turnover, enhance collagen synthesis, regulate sebum production, and mitigate inflammatory responses. These actions collectively lead to observable reductions in fine lines and wrinkles, improvements in skin elasticity and texture, diminished hyperpigmentation, and control of acne breakouts. The esterified form also suggests a slower skin penetration, facilitating a gradual release and thereby minimizing the risk of irritation.
Research
Clinical Evidence
High confidenceEfficacy is observed from 0.1%, with significant anti-aging benefits noted at 0.2% and 0.5%.
Key findings
- 01 A topical serum containing 0.1% HPR combined with peptides demonstrated anti-aging results comparable to a fractional CO2 laser over 16 weeks, with significant improvements across 16 parameters related to photodamage and aging skin.
- 02 Products containing 0.2% HPR are effective for anti-aging, with manufacturer's tests showing a 'dramatic reduction of lines and wrinkles' around the eyes after twice-daily application for 14 days.
- 03 Treatment with 0.5% HPR resulted in significant anti-aging improvement for 80% of patients after 50 days, reaching 100% after 90 days.
- 04 An optimal 5:9 ratio of HPR to Retinyl Propionate was found to stimulate human fibroblast proliferation and increase collagen production.
Transparency
Dusting Analysis
Hydroxypinacolone Retinoate demonstrates significant clinical efficacy at relatively low concentrations, with observable anti-aging benefits starting from 0.1% and substantial improvements at 0.2% and 0.5%. While products often utilize it up to 1%, concentrations significantly exceeding this maximum advised threshold may not yield proportionally increased clinical benefits, thus warranting careful formulation review.
The Formula
Formulation
Stability
HPR exhibits superior stability compared to retinol, demonstrating increased resistance to degradation from light and air. Formulations containing HPR (e.g., Granactive Retinoid) show prominent stability, with 95-97% content integrity maintained at elevated temperatures (25°C to 40°C) over 6 months. However, as it is light-sensitive, it should be stored in opaque, airtight, light-protected packaging and ideally applied during evening routines.
Synergies
- Retinyl Propionate (optimal 5:9 HPR:RP ratio for collagen and fibroblast proliferation)
Conflicts
- Exfoliating acids (AHAs, BHAs) due to potential irritation amplification
- Other retinoid treatments, as per specific product formulation guidelines, to prevent excessive irritation
Safety
Safety Profile
Hydroxypinacolone Retinoate is generally well-tolerated and causes less skin irritation compared to more conventional retinoids like retinol and retinoic acid. Mild redness, dryness, or peeling may occur initially, particularly in individuals with sensitive skin, though manufacturer tests suggest significantly lower irritation from 0.5% HPR versus 0.5% retinol. Daily use of broad-spectrum sunscreen is imperative during HPR treatment due to its light sensitivity.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Hydroxypinacolone Retinoate is a valuable, well-tolerated next-generation retinoid that effectively addresses signs of aging and acne with a notably lower irritation profile, making it suitable for a broad spectrum of skin types.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources